[ad_1]
The decision of the European Medicines Agency (EMA) was approved by the European Commission, the executive body of the European Union.
In her statement on the matter, EU Commission President Ursula von der Leyen said that following the EMA’s decision, distribution of vaccines produced at Pfizer’s facilities in Belgium to EU members will begin. within a few days, with the permission of the EU Commission.
Von der Leyen announced that vaccinations could start on December 27, 28 and 29 in all EU countries.
Stating that the EMA will make the decision on the approval of the vaccine developed by the American pharmaceutical company Moderna on January 6, von der Leyen said that, as the EU, they will help low-income countries provide vaccines.
EMA HAS MADE THE ADVICE DECISION
The EMA official stated that after the recommendation, there was no evidence that the BioNTech / Pfizer vaccine did not provide immunity against the new virus.
The decision was made after a closed session, where EMA scientists tasked with evaluating the vaccine presented their analysis to other experts and examined data received from the companies.
Officials said that an extraordinary effort has been made in recent days to find out if the vaccine is safe and that human health is its first priority.
class = “cf”>
LEYEN PROMOTED THE DECISION ON TWITTER
European Commission President Ursula Von der Leyen praised the EMA’s recommendation for the Pfizer / BioNTech vaccine in a statement after the decision.
“It is a watershed moment in our efforts to provide Europeans with a safe and effective vaccine,” Leyen said in a message on his Twitter account.
